Unlock stock picks and a broker-level newsfeed that powers Wall Street.

ASX - Delayed Quote AUD

Imugene Limited (IMU.AX)

Compare
0.0240
0.0000
(0.00%)
At close: 4:10:17 PM GMT+10
Currency in AUD All numbers in thousands
Download
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
145,700.5730
145,700.5730
51,293.2260
50,673.1430
25,666.1490
Operating Income
-145,700.5730
-145,700.5730
-51,293.2260
-50,673.1430
-25,666.1490
Net Non Operating Interest Income Expense
4,037.2620
4,037.2620
1,852.3490
71.9250
10.5090
Other Income Expense
-8,017.2280
-8,017.2280
11,525.9870
12,732.0440
7,200.2770
Pretax Income
-149,680.5390
-149,680.5390
-37,914.8900
-37,869.1740
-18,455.3630
Net Income Common Stockholders
-149,680.5390
-149,680.5390
-37,914.8900
-37,869.1740
-18,455.3630
Basic EPS
-0.02
--
-0.01
-0.01
-0.00
Diluted EPS
-0.02
--
-0.01
-0.01
-0.00
Basic Average Shares
7,088,807.7040
--
6,317,915.9680
5,637,196.7970
4,663,540.9720
Diluted Average Shares
7,088,807.7040
--
6,317,915.9680
5,637,196.7970
4,663,540.9720
Net Income from Continuing & Discontinued Operation
-149,680.5390
-149,680.5390
-37,914.8900
-37,869.1740
-18,455.3630
Normalized Income
-138,418.0220
-138,418.0220
-37,912.4810
-37,764.3250
-18,455.3630
Interest Income
4,515.6230
4,515.6230
1,879.8020
192.2490
126.5650
Interest Expense
--
--
--
106.7440
111.0320
Net Interest Income
4,037.2620
4,037.2620
1,852.3490
71.9250
10.5090
EBIT
-145,700.5730
-145,700.5730
-51,293.2260
-37,762.4300
-18,344.3310
EBITDA
-142,411.8430
-142,411.8430
-51,102.9060
-37,559.0730
-18,240.1280
Reconciled Depreciation
3,288.7300
3,288.7300
190.3200
203.3570
104.2030
Net Income from Continuing Operation Net Minority Interest
-149,680.5390
-149,680.5390
-37,914.8900
-37,869.1740
-18,455.3630
Total Unusual Items Excluding Goodwill
-11,262.5170
-11,262.5170
-2.4090
-104.8490
--
Total Unusual Items
-11,262.5170
-11,262.5170
-2.4090
-104.8490
--
Normalized EBITDA
-131,149.3260
-131,149.3260
-51,100.4970
-37,454.2240
-18,240.1280
6/30/2021 - 12/30/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CHM.AX Chimeric Therapeutics Limited
0.0050
0.00%
 
RAD.AX Radiopharm Theranostics Limited
0.0230
+9.52%
 
RAC.AX Race Oncology Limited
1.0200
-0.97%
 
OCC.AX Orthocell Limited
1.4200
-5.33%
 
IMM.AX Immutep Limited
0.2400
0.00%
 
CU6.AX Clarity Pharmaceuticals Ltd
1.6150
-2.42%
 
ZLD.AX Zelira Therapeutics Limited
0.4700
0.00%
 
PTX.AX Prescient Therapeutics Limited
0.0420
+2.44%
 
SPL.AX Starpharma Holdings Limited
0.0980
0.00%
 
ALA.AX Arovella Therapeutics Limited
0.0820
+1.23%